Top Markets
#1 GEKKO GEKKO +51.79%
#2 Helium Helium +45.36%
#3 ADO Protocol ADO Protocol +38.91%
#4 Prom Prom +34.97%
#5 Pons Pons +33.94%
#6 TENDIES TENDIES +31.01%
#7 Collector Crypt Collector Crypt +28.01%
#8 StonkBroker StonkBroker +26.08%
#9 Collect on Fanable Collect on Fanable +20.42%
#10 Cysic Cysic +20.13%
Coin of the day
GEKKO GEKKO
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)

Xvivo Perfusion AB (publ)

XVIVO
Xếp hạng trong cổ phiếu #9727
Xvivo Perfusion AB (publ) is a medical technology company that creates and... Xvivo Perfusion AB (publ) is a medical technology company that creates and supplies advanced solutions for the preservation and perfusion of organs, tissues, and cells, primarily for use in transplantation. The company's global reach extends across Sweden, the United States, both North and South America, Europe, the Middle East, Africa, and the Asia Pacific region. Its product line includes the XVIVO System (XPS), an integrated, ready-to-use cardiac bypass system designed to facilitate safe normothermic ex vivo lung perfusion (EVLP). To support this, the XPS Disposable Lung Kit offers all the necessary sterile, pre-packed components for EVLP procedures. Xvivo also provides STEEN Solution, an optimally formulated buffered extracellular solution specifically for perfusing isolated donor lungs during EVLP. Additional offerings comprise Perfadex Plus, an extracellular, low-potassium, dextran-based electrolyte preservation solution, and the XVIVO Silicone Tubing Set, used for efficient flushing of donor lungs during the procurement process. The company also manufactures the XVIVO LS and XVIVO Disposable Lung Set, both critical devices for EVLP. Furthermore, Xvivo provides the XVIVO Organ Chamber, a sterile, single-use disposable container for temporarily housing isolated lungs before transplantation, and the XVIVO Lung Cannula Set, another sterile, single-use disposable medical product. Established in 1998, Xvivo Perfusion AB (publ) is headquartered in Gothenburg, Sweden.
Giá cổ phiếu
$30.43
Đồng bộ lần cuối: 2026-08-28
Vốn hóa thị trường
$958.38M
Thay đổi (1 ngày)
-3.95%
Thay đổi (1 năm)
71.66%
Quốc gia
SE
Giao dịch Xvivo Perfusion AB (publ) (XVIVO)

Danh mục

Healthcare
Lịch sử giá cổ phiếu của Xvivo Perfusion AB (publ) (XVIVO)
Giá đóng cửa cao nhất: $31.90 vào 2026-08-01

Giá đóng cửa thấp nhất: $3.27 vào 2012-10-01
Lịch sử giá cổ phiếu của Xvivo Perfusion AB (publ) từ 2012 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) 24.30%
2025 -54.32%
2024 47.50%
2023 58.97%
2022 -37.57%
2021 -21.09%
2020 109.04%
2019 16.25%
2018 38.58%
2017 12.67%
2016 43.64%
2015 33.79%
2014 1.65%
2013 61.13%
2012 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $112.64 -15.09%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $331.44 -15.32%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $91.30 -1.63%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $46.83 -55.61%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 $46.88 -15.20%
DE